5-chloro-2'-deoxycytidine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottlieb, C; Greer, S; Marion, HS; Santos, O; Schwade, J | 1 |
| Brown, JM; Rice, GC; Russell, KJ | 1 |
2 other study(ies) available for 5-chloro-2'-deoxycytidine and Experimental Neoplasms
| Article | Year |
|---|---|
5-chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and Lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Combined Modality Therapy; Deoxycytidine; Fibrosarcoma; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radiation-Sensitizing Agents | 1992 |
In vitro and in vivo radiation sensitization by the halogenated pyrimidine 5-chloro-2'-deoxycytidine.
Topics: Animals; Bromodeoxyuridine; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Deoxycytidine; Female; Flow Cytometry; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Radiation-Sensitizing Agents; Tetrahydrouridine | 1986 |